X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-bictegravir-sodium-emtricitabine-and-tenofovir-alafenamide-fumarate-tablets-80375.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-bictegravir-sodium-emtricitabine-tenofovir-alafenamide-fumarate-tablet-1649312230.pdf
https://www.raps.org/news-and-articles/news-articles/2019/5/fda-unveils-34-new-and-revised-product-specific-dr
https://en.prnasia.com/releases/apac/singapore-health-sciences-authority-approves-biktarvy-r-bictegravir-emtricitabine-tenofovir-alafenamide-for-treatment-of-hiv-1-infection-237107.shtml
https://www.fiercepharma.com/pharma/as-advair-generic-hits-gsk-looks-to-oncology-as-new-growth-point-alongside-shingrix-and-hiv
https://www.biospace.com/article/yale-researchers-discover-protein-in-the-immune-system-can-help-suppress-hiv/
https://www.gilead.com/news/press-releases/2018/6/european-commission-grants-marketing-authorization-for-gileads-biktarvy-bictegravir-emtricitabine-tenofovir-alafenamide-for-the-treatment-of-hiv1-infection
https://endpts.com/gsk-vs-gilead-heavyweight-hiv-fight-will-come-down-to-a-big-showdown-in-amsterdam-next-month/
http://www.pharmatimes.com/news/three_medicines_step_closer_to_eu_approval_1233733
https://www.fiercepharma.com/corporate/gilead-strikes-back-at-gsk-positive-hiv-head-to-head-trial-data
http://www.pharmatimes.com/news/us_green_light_for_gileads_hiv_combo_1220972
https://endpts.com/with-hep-c-cash-dwindling-gilead-gets-a-blockbuster-boost-from-an-fda-ok-of-hiv-triplet-biktarvy/
https://www.fiercepharma.com/financials/cvs-unitedhealthcare-formulary-moves-hit-sanofi-s-diabetes-sales-hard
https://endpts.com/the-top-10-prospective-blockbuster-drug-launches-slated-for-2018-evaluate/
http://www.gilead.com/news/press-releases/2017/10/gilead-announces-new-license-agreement-with-the-medicines-patent-pool-for-access-to-bictegravir
http://www.biospace.com/News/gileads-hiv-triple-combo-gets-sped-up-fda-review/466251/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
Market Place
Share 
